SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYGN - Dynagen

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rupert Gittens who wrote (421)7/15/1999 3:00:00 PM
From: Tadsamillionaire  Read Replies (1) of 444
 
I can't resist.... SO WHAT! DYGN is a turn around company that has addressed all the issues filed in their last 10Q.
The Generic drug market is a key market coming of age in 1999-2000-2001. With the release of patents on medications that will be crucial for patients to have at lower costs. The consolidation of the drug market and the efforts of Mr.Cusick should prove to be profitable for the company and the stock holders.
Where were you when this was .15 cents a share and everyone that read read their 10Q agreed they were out of cash and as the 10Q stated they may not stay in business for 30 more days!
Thats the difference between great management of a hot company and someone looking for a quick 2 cent day trade. DYGN IS A LONG TERM hold. You need to do a bit more Due Diligence on the company and Mr. Cusick.
By the way , say hello to Ditchdigger, and ask if he is still holding that stellar company Consolidated Eco Systems? EXSO..
JMHO I am Long on DYGN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext